1. Home
  2. NN vs CPRX Comparison

NN vs CPRX Comparison

Compare NN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NN
  • CPRX
  • Stock Information
  • Founded
  • NN 2007
  • CPRX 2002
  • Country
  • NN United States
  • CPRX United States
  • Employees
  • NN N/A
  • CPRX N/A
  • Industry
  • NN Industrial Machinery/Components
  • CPRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NN Industrials
  • CPRX Health Care
  • Exchange
  • NN Nasdaq
  • CPRX Nasdaq
  • Market Cap
  • NN 2.4B
  • CPRX 2.6B
  • IPO Year
  • NN N/A
  • CPRX 2006
  • Fundamental
  • Price
  • NN $14.38
  • CPRX $20.82
  • Analyst Decision
  • NN
  • CPRX Strong Buy
  • Analyst Count
  • NN 0
  • CPRX 5
  • Target Price
  • NN N/A
  • CPRX $33.20
  • AVG Volume (30 Days)
  • NN 1.4M
  • CPRX 1.6M
  • Earning Date
  • NN 11-12-2025
  • CPRX 11-05-2025
  • Dividend Yield
  • NN N/A
  • CPRX N/A
  • EPS Growth
  • NN N/A
  • CPRX 183.96
  • EPS
  • NN N/A
  • CPRX 1.65
  • Revenue
  • NN $6,259,000.00
  • CPRX $558,499,000.00
  • Revenue This Year
  • NN N/A
  • CPRX $16.51
  • Revenue Next Year
  • NN N/A
  • CPRX $9.58
  • P/E Ratio
  • NN N/A
  • CPRX $12.64
  • Revenue Growth
  • NN 42.80
  • CPRX 28.55
  • 52 Week Low
  • NN $7.49
  • CPRX $19.05
  • 52 Week High
  • NN $18.54
  • CPRX $26.58
  • Technical
  • Relative Strength Index (RSI)
  • NN 37.08
  • CPRX 58.08
  • Support Level
  • NN $14.08
  • CPRX $19.05
  • Resistance Level
  • NN $17.87
  • CPRX $21.07
  • Average True Range (ATR)
  • NN 0.74
  • CPRX 0.59
  • MACD
  • NN -0.27
  • CPRX 0.16
  • Stochastic Oscillator
  • NN 5.54
  • CPRX 60.27

About NN NextNav Inc.

NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

Share on Social Networks: